Literature DB >> 15571493

The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Sarah Bourbigot1, Hervé Beltz, Jérôme Denis, Nelly Morellet, Bernard P Roques, Yves Mély, Serge Bouaziz.   

Abstract

HIV-1 Vpr is a highly conserved accessory protein that is involved in many functions of the virus life cycle. Vpr facilitates the entry of the HIV pre-integration complex through the nuclear pore, induces G2 cell cycle arrest, regulates cell apoptosis, increases transcription from the long terminal repeat and enhances viral replication. Vpr contains a Leu/Ile-rich domain (amino acids 60-81) in its C-terminal part, which is critical for dimerization. The sequence comprising residues 52-96 is implicated in properties of the protein such as DNA interaction and apoptosis via interaction with the adenine nucleotide translocator. To understand the specific interactions of Vpr-(52-96), the ability of this peptide to dimerize via a leucine-zipper mechanism has been investigated, by NMR and fluorescence spectroscopy. In contrast with results from a study performed in the presence of trifluoroethanol, our results, obtained in 30% (v/v) [2H]acetonitrile, show that Vpr-(52-96) in solution still forms an a-helix spanning residues 53-75, but dimerizes in an antiparallel orientation, through hydrophobic interactions between leucine and isoleucine residues and stacking between His71 and Trp54. Moreover, to demonstrate the physiological relevance of the dimer structure, fluorescence spectroscopy experiments have been performed in a Mes buffer, which confirmed the formation of the dimer in aqueous solution and highlighted the spatial proximity between Trp54 and His71. Surprisingly, the leucine-zipper structure shown in the present work for Vpr-(52-96) mimics the structure of full-length Vpr-(1-96), and this could explain why some of the properties of Vpr-(52-96) and Vpr-(1-96) are identical, while some are even enhanced for Vpr-(52-96), particularly in the case of DNA transfection experiments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15571493      PMCID: PMC1134961          DOI: 10.1042/BJ20041759

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro.

Authors:  V Ayyavoo; S Mahalingam; Y Rafaeli; S Kudchodkar; D Chang; T Nagashunmugam; W V Williams; D B Weiner
Journal:  J Leukoc Biol       Date:  1997-07       Impact factor: 4.962

2.  AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR.

Authors:  R A Laskowski; J A Rullmannn; M W MacArthur; R Kaptein; J M Thornton
Journal:  J Biomol NMR       Date:  1996-12       Impact factor: 2.835

3.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.

Authors:  S A Stewart; B Poon; J B Jowett; I S Chen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Characterization of a leucine-zipper-like domain in Vpr protein of human immunodeficiency virus type 1.

Authors:  L Wang; S Mukherjee; O Narayan; L J Zhao
Journal:  Gene       Date:  1996-10-31       Impact factor: 3.688

5.  Solution structure of human immunodeficiency virus type 1 Vpr(13-33) peptide in micelles.

Authors:  A Engler; T Stangler; D Willbold
Journal:  Eur J Biochem       Date:  2001-01

6.  Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation.

Authors:  X J Yao; R A Subbramanian; N Rougeau; F Boisvert; D Bergeron; E A Cohen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities.

Authors:  M Nilges
Journal:  J Mol Biol       Date:  1995-02-03       Impact factor: 5.469

8.  The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr.

Authors:  H de Rocquigny; P Petitjean; V Tanchou; D Decimo; L Drouot; T Delaunay; J L Darlix; B P Roques
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

9.  A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradients.

Authors:  J Schleucher; M Schwendinger; M Sattler; P Schmidt; O Schedletzky; S J Glaser; O W Sørensen; C Griesinger
Journal:  J Biomol NMR       Date:  1994-03       Impact factor: 2.835

10.  The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.

Authors:  J B Jowett; V Planelles; B Poon; N P Shah; M L Chen; I S Chen
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more
  20 in total

Review 1.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

2.  Vipirinin, a coumarin-based HIV-1 Vpr inhibitor, interacts with a hydrophobic region of VPR.

Authors:  Eugene Boon Beng Ong; Nobumoto Watanabe; Akiko Saito; Yushi Futamura; Khaled Hussein Abd El Galil; Atsushi Koito; Nazalan Najimudin; Hiroyuki Osada
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

3.  Computational analysis of residue contributions to coiled-coil topology.

Authors:  Jorge Ramos; Themis Lazaridis
Journal:  Protein Sci       Date:  2011-09-20       Impact factor: 6.725

Review 4.  Protein intrinsic disorder as a flexible armor and a weapon of HIV-1.

Authors:  Bin Xue; Marcin J Mizianty; Lukasz Kurgan; Vladimir N Uversky
Journal:  Cell Mol Life Sci       Date:  2011-10-28       Impact factor: 9.261

5.  Human polyomavirus JC small regulatory agnoprotein forms highly stable dimers and oligomers: implications for their roles in agnoprotein function.

Authors:  A Sami Saribas; Buenafe T Arachea; Martyn K White; Ronald E Viola; Mahmut Safak
Journal:  Virology       Date:  2011-09-13       Impact factor: 3.616

6.  JC virus agnoprotein enhances large T antigen binding to the origin of viral DNA replication: evidence for its involvement in viral DNA replication.

Authors:  A Sami Saribas; Martyn K White; Mahmut Safak
Journal:  Virology       Date:  2012-07-27       Impact factor: 3.616

7.  PP2A1 binding, cell transducing and apoptotic properties of Vpr(77-92): a new functional domain of HIV-1 Vpr proteins.

Authors:  Angélique N Godet; Julien Guergnon; Amélie Croset; Xavier Cayla; Pierre Barthélemy Falanga; Jean-Hervé Colle; Alphonse Garcia
Journal:  PLoS One       Date:  2010-11-01       Impact factor: 3.240

8.  Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles.

Authors:  Narasimhan J Venkatachari; Leah A Walker; Oznur Tastan; Thien Le; Timothy M Dempsey; Yaming Li; Naveena Yanamala; Alagarsamy Srinivasan; Judith Klein-Seetharaman; Ronald C Montelaro; Velpandi Ayyavoo
Journal:  Virol J       Date:  2010-06-07       Impact factor: 4.099

9.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

10.  The immunosuppressive properties of the HIV Vpr protein are linked to a single highly conserved residue, R90.

Authors:  Irina Tcherepanova; Aijing Starr; Brad Lackford; Melissa D Adams; Jean-Pierre Routy; Mohamed Rachid Boulassel; David Calderhead; Don Healey; Charles Nicolette
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.